Veeva Systems Inc. which can be found using ticker (VEEV) have now 24 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between $270.00 and $200.00 suggesting an average analyst share price target price of $241.47. (at the time of writing). Given that the stocks previous close was at $201.58 this is indicating there is a potential upside of 19.8%. It’s also worth noting that there is a 50 day moving average of $218.27 and the 200 day MA is $202.34. The market cap for the company is 32.09B. The current share price for the company is: $198.56 USD
The potential market cap would be $38,440,274,050 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 61.66, revenue per share of $14.72 and a 5.01% return on assets.
Veeva Systems Inc. is a provider of industry cloud solutions for the global life sciences industry. The Company’s offerings span cloud software, data, and business consulting and are designed to meet the needs of its customers and their most strategic business functions from research and development (R&D) to commercialization. The Company’s industry cloud solutions for the life sciences industry are grouped into two major product families: Veeva Development Cloud and Veeva Commercial Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its proprietary Veeva Vault platform. Veeva Commercial Cloud includes solutions for the sales, medical affairs, and marketing functions of a life sciences company. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.
